The company said it would continue trials where patients are already
enrolled. The company added that it does not anticipate any change
to its full-year forecast as a result of the coronavirus outbreak.
(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
[© 2020 Thomson Reuters. All rights
Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.